You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

135 Results
Drug
Other Name(s): Lederle Leucovorin® (multiple brands available)
Apr 2019
Drug
Other Name(s): Tykerb®
Dec 2022
Drug
Other Name(s): Lupron® (AbbVie) , Lupron Depot® (AbbVie) , Eligard® (Sanofi Aventis)
Aug 2016
Drug
Other Name(s): CeeNU®
Aug 2024
Drug
Other Name(s): Lenvima®
Sep 2023
Drug
Other Name(s): Somatuline® Autogel®
Jun 2024
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Sep 2017
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Nov 2020
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    letrozole
Nov 2020
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
May 2022
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Funding:
ODB - General Benefit
    lomustine
Aug 2024
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • leuprolide - long-acting formulation
Jun 2017

Pages